RhythmAnalytics vs Eko Analysis Software
AI Verdict
Choose RhythmAnalytics if…
Choose RhythmAnalytics if your primary need is automated, comprehensive interpretation of a wide range of cardiac arrhythmias from diverse single-lead ECG data sources. This cloud-based API solution is ideal for healthcare systems or integrators seeking to enhance clinical decision support with detailed, AI-powered ECG analysis from Holter monitors, event recorders, or wearable sensors.
View RhythmAnalytics →Choose Eko Analysis Software if…
Choose Eko Analysis Software if you are a clinician utilizing Eko's digital stethoscopes and require an integrated solution for real-time auscultation and AI-powered screening for heart murmurs and atrial fibrillation. This tool is best suited for point-of-care assessments, allowing for immediate recording, playback, and visualization of heart sounds and ECGs directly within a mobile app environment.
View Eko Analysis Software →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | RhythmAnalytics | Eko Analysis Software |
|---|---|---|
| Pricing | Contact vendor | Freemium with subscription for full features |
| Deployment | Cloud-based API | Cloud-based |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Analysis SoftwareTool B offers a more direct and integrated user experience for clinicians through its dedicated digital stethoscopes and mobile application, including clear user manuals and troubleshooting guides. Tool A, primarily an API, relies on third-party integration for its end-user interface, making its direct usability less apparent for a clinician.
Clinical Value
Eko Analysis SoftwareBoth tools offer significant clinical value with FDA clearances. Tool A provides comprehensive arrhythmia detection from ECG data, covering over 15 types. However, Tool B uniquely integrates AI with digital stethoscopes for point-of-care detection of heart murmurs (including timing and severity across all ages), atrial fibrillation, and low ejection fraction, offering a broader diagnostic scope for cardiovascular assessment.
Pricing & Value
Eko Analysis SoftwareTool B clearly wins in pricing transparency and value, offering a freemium model with detailed subscription tiers for its full features. This allows users to explore basic functionalities for free. Tool A's 'contact vendor' pricing lacks transparency and immediate value proposition.
Enterprise Readiness
Eko Analysis SoftwareTool B explicitly states it has Business Associate Agreements (BAA) and is SOC 2 certified, which are critical for enterprise adoption and data security in healthcare. It also provides dedicated resources for enterprise customers. While Tool A is designed for integration and used by major institutions, the BAA status for RhythmAnalytics itself is unspecified in the provided data, posing a potential hurdle for enterprise clients.
Innovation
Eko Analysis SoftwareBoth tools are highly innovative. Tool A's innovation lies in its deep learning for comprehensive and highly accurate arrhythmia detection from ECG, outperforming other systems and cardiologists in some metrics. Tool B's innovation is in integrating AI with a physical digital stethoscope for real-time, point-of-care detection of multiple cardiovascular conditions (murmurs, AFib, low ejection fraction), including the 'first FDA-cleared foundation model for cardiovascular AI,' offering a more integrated and novel approach to diverse point-of-care diagnostics.
Support & Docs
Eko Analysis SoftwareTool B provides more accessible and comprehensive support and documentation for both individual users and enterprise customers through its dedicated Eko Help Center, offering user manuals, troubleshooting guides, FAQs, and direct support contact options. Tool A's support and documentation for RhythmAnalytics as a standalone product are not readily apparent for end-users, leaning more towards integrator documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | RhythmAnalytics | Eko Analysis Software |
|---|---|---|
| Name | RhythmAnalytics | Eko Analysis Software |
| Company | Biofourmis Singapore Pte. | Eko Devices |
| Description | FDA-cleared, AI-powered cloud-based software that provides automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support for healthcare professionals and integrators. | FDA-cleared AI-powered tool that integrates with Eko's digital stethoscopes and mobile app to assist clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation. |
| Key AI Detections | Over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats) | Heart murmur detection, Atrial Fibrillation (AFib) detection, normal sinus rhythm |
Videos
Demos, reviews, and walkthroughs featuring RhythmAnalytics and Eko Analysis Software.